Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification

Yan Wang; Fuhao Chu; Jie Lin; Yuan Li; Nadia Johnson; Jianglan Zhang; Cong Gai; Zeqi Su; Hong-Jie Cheng; Linheng Wang; Xia Ding

doi:10.1016/j.jep.2021.114399

Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification

Yan Wang(Beijing University of Chinese Medicine), Fuhao Chu(Beijing University of Chinese Medicine), Jie Lin(Beijing University of Chinese Medicine), Yuan Li(Beijing University of Chinese Medicine), Nadia Johnson(Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine), Jianglan Zhang(Beijing University of Chinese Medicine), Cong Gai(Beijing University of Chinese Medicine), Zeqi Su(Beijing University of Chinese Medicine), Hong-Jie Cheng(Beijing University of Chinese Medicine), Linheng Wang(Beijing University of Chinese Medicine), Xia Ding(Beijing University of Chinese Medicine)

Journal of Ethnopharmacology

July 8, 2021

10.1016/j.jep.2021.114399

Cited by 90

Abstract

Related Papers

No related papers found

Powered by citation graph analysis